Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Ma

Showing results (291-300 of 357) with videos related to

Pageof 36
Sort By:
JMIR Research Protocols|August 1, 2025
Developing and Evaluating a Bundled Digital Tool to Improve Complex Care and Self-Management of Patients With Inflammatory Bowel Disease: Protocol for a Hybrid Effectiveness-Implementation StudyKaitlyn Delaney Chappell, Melissa Fox, Thomas Scott Armstrong, et al.
BMJ Open Gastroenterology|January 20, 2022
Crohn's disease therapeutic dietary intervention (CD-TDI): study protocol for a randomised controlled trialMaitreyi Raman, Christopher Ma, Lorian M Taylor, et al.
Clinical and Translational Gastroenterology|March 29, 2022
Declining Colectomy Rates for Nonmalignant Colorectal Polyps in a Large, Ethnically Diverse, Community-Based PopulationAsim Alam, Christopher Ma, Sheng-Fang Jiang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 2, 2019
Reliability of Endoscopic Evaluation of Postoperative Recurrent Crohn's DiseaseChristopher Ma, Krisztina B Gecse, Marjolijn Duijvestein, et al.
Digestive Diseases and Sciences|March 17, 2025
Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort StudyLisa M A van Lierop, Larissa Albino, Ryan Rosentreter, et al.
The American Journal of Gastroenterology|May 9, 2020
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule InhibitorsParambir S Dulai, Robert Battat, Maria Barsky, et al.
Journal of Crohn'S & Colitis|November 9, 2025
Placebo rates in randomized clinical trials of ulcerative colitis: an individual patient data meta-analysisVirginia Solitano, Malcolm Hogan, Siddharth Singh, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2024
Performance of bowel preparation quality scales in patients with Crohn's diseaseVirginia Solitano, Corey A Siegel, Joshua R Korzenik, et al.
The New England Journal of Medicine|September 25, 2024
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative ColitisBruce E Sands, Brian G Feagan, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis|July 26, 2021
Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative ColitisRocio Sedano, Malcolm Hogan, Tran M Nguyen, et al.
Pageof 36

Showing results (291-300 of 357) with videos related to

Sort By:
Pageof 36
JMIR Research Protocols|August 1, 2025
Developing and Evaluating a Bundled Digital Tool to Improve Complex Care and Self-Management of Patients With Inflammatory Bowel Disease: Protocol for a Hybrid Effectiveness-Implementation StudyKaitlyn Delaney Chappell, Melissa Fox, Thomas Scott Armstrong, et al.
BMJ Open Gastroenterology|January 20, 2022
Crohn's disease therapeutic dietary intervention (CD-TDI): study protocol for a randomised controlled trialMaitreyi Raman, Christopher Ma, Lorian M Taylor, et al.
Clinical and Translational Gastroenterology|March 29, 2022
Declining Colectomy Rates for Nonmalignant Colorectal Polyps in a Large, Ethnically Diverse, Community-Based PopulationAsim Alam, Christopher Ma, Sheng-Fang Jiang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 2, 2019
Reliability of Endoscopic Evaluation of Postoperative Recurrent Crohn's DiseaseChristopher Ma, Krisztina B Gecse, Marjolijn Duijvestein, et al.
Digestive Diseases and Sciences|March 17, 2025
Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort StudyLisa M A van Lierop, Larissa Albino, Ryan Rosentreter, et al.
The American Journal of Gastroenterology|May 9, 2020
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule InhibitorsParambir S Dulai, Robert Battat, Maria Barsky, et al.
Journal of Crohn'S & Colitis|November 9, 2025
Placebo rates in randomized clinical trials of ulcerative colitis: an individual patient data meta-analysisVirginia Solitano, Malcolm Hogan, Siddharth Singh, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2024
Performance of bowel preparation quality scales in patients with Crohn's diseaseVirginia Solitano, Corey A Siegel, Joshua R Korzenik, et al.
The New England Journal of Medicine|September 25, 2024
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative ColitisBruce E Sands, Brian G Feagan, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis|July 26, 2021
Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative ColitisRocio Sedano, Malcolm Hogan, Tran M Nguyen, et al.
Pageof 36